CVE:ZMD ZoomMed (ZMD) Stock Price, News & Analysis C$0.02 +0.02 (+∞) (As of 10/4/2018) Add Compare Share Share Stock Analysis Stock Analysis About ZoomMed Stock (CVE:ZMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get ZoomMed alerts:Sign Up Key Stats Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.05Volume220,000 shsAverage Volume290,486 shsMarket CapitalizationC$2.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.Read More… War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Receive ZMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZoomMed and its competitors with MarketBeat's FREE daily newsletter. Email Address ZMD Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com ZMD Stock Analysis - Frequently Asked Questions How have ZMD shares performed this year? ZoomMed's stock was trading at C$0.02 at the beginning of 2024. Since then, ZMD shares have increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. How do I buy shares of ZoomMed? Shares of ZMD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeCVE SectorComputer and Technology Industry Health Information Services Sub-IndustryN/A Current SymbolCVE:ZMD CUSIPN/A CIKN/A Webzoommedcorpo.com Phone+1-450-6785457FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesC$10,000.00 Price / Sales203.39 Cash FlowN/A Price / Cash FlowN/A Book ValueC($0.02) per share Price / Book-0.88Miscellaneous Outstanding Shares135,591,000Free FloatN/AMarket CapC$2.03 million OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (CVE:ZMD) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZoomMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZoomMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.